Company: SXTPW
Filing Date: 2025-07-18
Form Type: SCHEDULE 13G
Source: 0001213900-25-065799
Chunk: 2

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-07-18
Form: SCHEDULE 13G
Chunk 2
---
 as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Common Stock, (VII) 101,861 shares of Common Stock issuable upon exercise of a fourth warrant held by Intracoastal ("Intracoastal Warrant 7") because Intracoastal Warrant 7 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 7 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Common Stock and (VIII) 75,175 shares of Common Stock issuable upon exercise of a fifth warrant held by Intracoastal ("Intracoastal Warrant 8") because Intracoastal Warrant 8 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 8 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Common Stock. Without such blocker provisions, each of the Reporting Persons may have been deemed to have beneficial ownership of 1,756,485 shares of Common Stock. 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     (ii)  As of the close of business on July 18, 2025, each of the Reporting Persons may have been deemed to have beneficial ownership of 372,429 shares of Common Stock, which consisted of (i) 45,612 shares of Common Stock held by Intracoastal, (ii) 189,316 shares of Common Stock issuable upon exercise of Intracoastal Warrant 1 and (iii) 137,501 shares of Common Stock issuable upon exercise of Intracoastal Warrant 2, and all such shares of Common Stock represent beneficial ownership of approximately 9.99% of the Common Stock, based on (1) 1,472,891 shares of Common Stock outstanding as of July 2, 2025, as reported by the Issuer, plus (2) 1,753,314